Neonatal pigmentation

Neonatal Skin: Structure and Function, Second Edition, Revised and Expanded

Volumn , Issue , 2003, Pages 89-108

  Fein, Howard ^a   Nordlund, James J ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Group Health Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889613730     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (67)

1. Nordlund JJ, Ortonne JP. The normal color of human skin. In: Nordlund JJ, et al., eds. Pigmentary System: Physiology and Pathophysiology. New York: Oxford University Press: 1998:475-488.
2. Quevedo WC, Holstein TJ. General biology of mammalian pigmentation. In: Nordlund JJ, et al., eds. Pigmentary System: Physiology and Pathophysiology. New York: Oxford University Press, 1998:43-58.
3. Szabo G. Quantitative histological investigations on the melanocyte system of the human epidermis. In: Gordon M, ed. Pigment Cell Biology. New York: Academic Press, 1959:99-125.
4. Szabo G, et al. Racial differences in the fate of melanosomes in human epidermis. Nature 1969; 222:1081-1082.
5. Quevedo W.C., et al. Role of light in human skin color variation. Am J Physical Anthropol 1975; 43:393-408.
6. Quevedo W.C. Normal pigmentation: histology, cellular biology, and biochemistry. Ala J Med Sci 1979; 16:305-13.
7. Toda K, Pathak MA, Parrish JA, Fitzpatrick TB, Quevedo WC, Jr. Alteration of racial differences in melanosome distribution in human epidermis after exposure to ultraviolet light. Nat New Biol 1972; 236:143-145.
8. Liu CT, Chedekel MR. Pheomelanin photochemistry: photolysis of model compounds. Photochem Photobiol 1982; 36:251-254.
9. Scheibner A, McCarthy WH, Milton GW, Nordlund JJ. Langerhans cell and melanocyte distribution in “normal” human epidermis. Aust J Derm 1983; 24:9-16.
10. Scheibner A, Hollis DE, Murray E, McCarthy WH, Milton GW. Effects of exposure to ultraviolet light on epidermal Langerhans cells and melanocytes in Australians of aboriginal, Asian and Celtic descent. Photo-Dermatology 1987; 4:5-13.
11. Scheibner A, Hollis DE, Murray E, McCarthy WH, Milton GW. Effects of sunlight exposure on Langerhans cells and melanocytes in human epidermis. Photo-Dermatology 1986; 3:15-25.
12. Staricco RJ, Pinkus H. Quantitative and qualitative data on the pigment cells of the adult human epidermis. J Invest Dermatol 1957; 28:33.
13. Holbrook K, et al. The appearance, density and distribution of melanocytes in the human embryonic and fetal skin revealed by the anti-melanoma monoclonal antibody, HMB-45. Anat Embryol 1989; 180:443-455.
14. Holbrook K, et al. Melanocytes in human embryonic and fetal skin: a review and new findings. Pigment Cell Res 1988; 1(suppl 1):6-17.
15. Reedy M, et al. Regulation of melanoblast migration and differentiation. In: Nordlund JJ, et al., eds. The Pigmentary System: Physiology and Pathophysiology. New York: Oxford University Press, 1988:75-96.
16. Zimmerman A, Cornbleet T. The development of epidermal pigmentation in the negro fetus. J Invest Dermatol 1948; 11:383-395.
17. Post PW, Krauss AN, Walcman S, Auld PA. Skin reflectance of newborn infants from 25 to 44 weeks gestational age. Human Biol 1976; 48:541-57.
18. Heyl T. The skin of the pre-term baby—a visual appraisal. Clin Exp Dermatol 1986; 11:584-593.
19. James T. Natal ethnic sign in the Xhosa people. J R Soc Med 1989; 82:665.
20. Gilmcher M, Kostick RM, Szabo G. The epidermal melanocyte system in newborn human skin. A quantitative histologic study. J Invest Dermatol 1973; 61:344-347.
21. Zimmerman AA, Becker SW. Melanoblasts and melanocytes in fetal negro skin. Illinois Monographs in Medical Science, 6 (3). Urbana, IL: University of Illinois Press, 1-5.
22. Iwata M, Corn T, Iwata S, Everett MA, Fuller BB. The relationship between tyrosinase activity and skin color in human foreskins. J Invest Dermatol 1990; 1:9-15.
23. Frost-Mason S, Walpita D, McKay L. Melanotropin as a potential regulator of pigment pattern formation in embryonic skin. Pigment Cell Res 1992; suppl(2):262-265.
24. Bhardwaj RS, Luger TA. Proopiomelanocortin production by epidermal cells: evidence for an immune neuroendocrine network in the epidermis. Arch Dermatol Res 1994; 287:85-90.
25. Daynes RA, et al. Alpha-melanocyte-stimulating hormone exhibits target cell selectivity in its capacity to affect interleukin 1-inducible responses in vivo and in vitro. J Immunol 1987; 139:103-109.
26. Desarnaud F, et al. Molecular cloning, functional expression and pharmacological characterization of a mouse melanocortin receptor gene. Biochem J 1994; 299:367-373.
27. Swope VB, et al. A new role for epidermal cell-derived thymocyte activating factor/IL-1 as an antagonist for distinct epidermal cell function. J Immunol 1989; 142:1943-1949.
28. Adan RA, et al. Identification of antagonists for melanocortin MC3, MC4 and MC5 receptors. Eur J Pharmacol 1994; 269:331-337.
29. Adan RA, et al. Differential effects of melanocortin peptides on neural melanocortin receptors. Mol Pharmacol 1994; 46:1182-1190.
30. Birchall N, et al. Interactions between ultraviolet light and interleukin-1 on MSH binding in both mouse melanoma and human squamous carcinoma cells. Biochem Biophys Res Commun 1991; 175:839-845.
31. Cannon JG, et al. Alpha melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1. J Immunol, 1986; 137:2232-2236.
32. Catania A, Lipton JM. The neuropeptide a MSH: a key component of neuroimmunomodulation. Neuroimmunomodulation 1994; 1:93-99.
33. Lipton JM, Catania A, Ichiyama T. Marshaling the anti-inflammatory influence of the neuroimmunomodulator alpha-MSH. News Physiol Sci 2000; 15:192-195.
34. Hiltz ME, Catania A, Lipton JM. Alpha-MSH peptides inhibit acute inflammation induced in mice by rIL-1 beta, rIL-6, rTNF-alpha and endogenous pyrogen but not that caused by LTB4, PAF and rIL-8. Cytokine 1992; 4:320-328.
35. Jessop DS, Lightman SL, Chowdrey HS. Effects of a chronic inflammatory stress on levels of pro-opiomelanocortin-derived peptides in the rat spleen and thymus. J Neuroimmunol 1994; 49:197-203.
36. Macaluso A, et al. Antiinflammatory influences of alpha-MSH molecules: central neurogenic and peripheral actions. J Neurosci 1994; 14:2377-2382.
37. Martin LW, et al. Neuropeptide alpha-MSH antagonizes IL-6-and TNFinduced fever. Peptides 1991; 12:297-299.
38. Perretti M, et al. Pharmacology of interleukin-1-induced neutrophil migration. Agents Actions 1993; 38:C64-65.
39. Shimizu T, Streilein JW. Influence of alpha-melanocyte stimulating hormone on induction of contact hypersensitivity and tolerance. J Dermatol Sci 1994; 8:187-193.
40. Smith EM, et al. Immunosuppressive effects of corticotropin and melanotropin and their possible significance in human immunodeficiency virus infection. Proc Natl Acad Sci USA 1992; 89:782-786.
41. Tatro JB. Melanotropin receptors in the brain are differentially distributed and recognize both corticotropin and alpha-melanocyte stimulating hormone. Brain Res 1990; 536:124-132.
42. Taylor AW, Streilein JW, Cousins SW. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res 1992; 11:1199-1206.
43. Mauri A, Volpe A, Martellotta MC, Barra V, Piu U, Angioni G, Angioni S, Argiolas A. α-Melanocyte-stimulating hormone during human perinatal life. J Clin Endocrinol Metab 1993; 77:113-117.
44. Facchinetti F, Storchi AR, Furani S, Radi D, Genazzani AR. Pituitary changes of desacetyl-α-melanocyte stimulating hormone throughout development. Biol Neonate 1988; 54:86-92.
45. Fitzpatrick TB. The biology of pigmentation. Birth Defects: Original Article Series 7 (8):5-12, 1971.
46. Fitzpatrick TB, Szabo G, Seiji M, Quevedo WC. Biology of the melanocyte system. In: Fitzpatrick TB, et al., eds. Dermatology in General Medicine. New York: McGraw-Hill Book Company, 1979; 141-163.
47. Scheibner A, McCarthy WH, Milton GW, Nordlund JJ. Langerhans cell and melanocyte distribution in “normal” human epidermis. Aust J Dermatol 1983; 24:9-16.
48. Scheibner A, Hollis DE, Murray E, McCarthy WH, Milton GW. Effects of exposure to ultraviolet light on epidermal Langerhans cells and melanocytes in Australians of aboriginal, Asian and Celtic descent. Photo-Dermatology 1987; 4:5-13.
49. Ashworth J, Turbitt ML, Mackie R. The distribution and quantification of the Langerhans cell in normal human epidermis. Clin Exp Dermatol 1986; 11:153-158.
50. Slominski A, Paus R, Wortsman J. On the potential role of proopiomelanocortin in skin physiology and pathology. Mol Cell Endocrinol 1993; 93: C1-6.
51. Spiro J, et al. Effect of PUVA on plasma and skin immunoreactive alphamelanocyte stimulating hormone concentrations. Br J Dermatol 1987; 117:703-707.
52. Bock M, et al. Antipyresis caused by stimulation of vasopressinergic neurons and intraseptal or systemic infusions of gamma-MSH. Am J Physiol 1994; 266:R614-621.
53. Catania A, et al. Proopiomelanocortin-derived peptides and cytokines: relations in patients with acquired immunodeficiency syndrome. Clin Immunol Immunopathol 1993; 66:73-9.
54. Lyson K, McCann SM. Alpha-melanocyte-stimulating hormone abolishes IL-1-and IL-6-induced corticotropin-releasing factor release from the hypothalamus in vitro. Neuroendocrinology 1993; 58:191-195.
55. Lyson K, et al. Binding of anti-inflammatory a MSH and proinflammatory cytokines to receptors on melanoma cells. Neuroimmunomodulation 1994; 1:121-126.
56. Mozzanica N, et al. Plasma alpha-melanocyte-stimulating hormone, betaendorphin, met-enkephalin, and natural killer cell activity in vitiligo. J Am Acad Dermatol 1992; 26:693-700.
57. Uehara M, Miyauchi H, Tanaka S. Diminished contact sensitivity response in vitiliginous skin. Arch Dermatol 1984; 120:195-198.
58. Rheins LA, Palkowski MR, Nordlund JJ. Alterations in cutaneous immune reactivity to dinitrofluorobenzene in graying C57BL/vi.vi mice. J Invest Dermatol 1986; 86:539-546.
59. Hatchome N, Aiba S, Kato T, Torinuki W, Tagami H. Possible functional impairment of Langerhans’ cells in vitiliginous skin. Reduced ability to elicit dinitrochlorobenzene contact sensitivity reaction and decreased stimulatory effect in the allogeneic mixed skin cell lymphocyte culture reaction. Arch Dermatol 1987; 123:51-54.
60. Gilhar A, Aizen E, Ohana N, Etzioni A. Vitiliginous vs pigmented skin response to intradermal administration of interferon gamma. Arch Dermatol 1993; 129:600-604.
61. Hearing VJ. Regulation of melanin formation. In: Nordlund JJ, et al., eds. Pigmentary System: Physiology and Pathophysiology. New York: Oxford University Press, 1998:423-438.
62. King RA. Albinism. In: Nordlund JJ, et al., eds. Pigmentary System: Physiology and Pathophysiology. New York: Oxford University Press, 1998:553-574.
63. Manga P, Orlow SJ. Inverse correlation between pink-eyed dilution protein expression and induction of melanogenesis by bafilomycin A1. Pigment Cell Res 2001; 14:362-367.
64. Boissy RE, et al. Mutation in and lack of expression of tyrosinase related protein-1 (TRP-1) in melanoyctes from an individual with Brown oculocutaneous albinism: a new subtype of albinism classified as OCA-3. Am J Human Genet 1996; 58:1145-1156.
65. Brilliant M, Barsh G. Anatomy of pigment cell genes acting at the cellular level. In: Nordlund JJ, et al., eds. The Pigmentary System: Physiology and Pathophysiology. New York: Oxford University Press, 1998.
66. Spritz R. Piebaldism, Waardenburg syndrome, and related genetic disorders— molecular and genetic aspects. In: Nordlund JJ, et al., eds. The Pigmentary System: Physiology and Pathophysiology. New York: Oxford University Press, 1998:207-216.
67. Nordlund JJ, et al, eds. The Pigmentary System: Physiology and Pathophysiology. New York: Oxford University Press, 1998: 1096.